Real World Practices (RWP)

Projects demonstrating real world practices, such as treatment paths and stakeholder mapping, have been popular items of our service supply for a long time. Such reviews describing a local situation create a comprehensive overall picture of a therapeutic area and its treatment practices and decision-making processes, utilising different data sources in an extremely extensive manner.

Medaffcon has the ability to bring real world register or biobank data into projects and create Real World Practice (RWP) packages. Adding register data in a review contributes, for example, to a more specific identification of a patient group and its characteristics.

One reason for the popularity of the service is its adaptability to meet the customer’s needs

RWP projects produce in-depth objective information that can benefit many actors from different contexts. Our potential customers include both healthcare actors and the pharmaceutical industry. We tailor a solution that fits your needs.

Our RWP service concept responds e.g. to the following questions:

  • Which parties are involved in the decisions related to your therapeutic area and what sort of decision-making mechanisms do these parties have?
  • What sort of treatment paths and practices are used in the selected therapeutic area?
  • How and why the treatment practices and paths vary around the country?
  • Which uncertainty factors (e.g. lack of information) shape the overall situation?
  • What currently happens in your therapeutic area and how does the future look like?
  • What sort of potential solutions could be available?

 

Contact us and we will together tailor a research structure to meet your specific needs!

 

 

”As a project manager, I work as a part of the client company’s team. I can offer the customer an independent perspective and new ideas without the organizational pressure. As a Medaffcon’s employee, I can offer to the customer, for example, the best practice methods, because here in Medaffcon, extensive expertise combines.”
Elisa Tyynysniemi
Scientific Project Manager, Medaffcon Oy

We are more than happy to tell you more!

Jaana Ahlamaa, Medaffcon Oy
Jaana Ahlamaa
Medical and Market Access Director

Contact us

Our Real World Practices Experts:

Jaana Ahlamaa, Medaffcon Oy
Jaana Ahlamaa
Medical and Market Access Director
Jaana Ahlamaa, Medaffcon Oy

Jaana Ahlamaa

Medical and Market Access Director
MD (Specialist in Surgery), PhD

+358 50 5767 325 LinkedIn

Jaana began her career in the pharmaceutical industry as a Medical Advisor in different therapeutic areas, after which she became a Medical Affairs Manager. Jaana’s areas of responsibility have included, inter alia, sales permission, pharmacovigilance and marketing support functions. In 2006, Jaana became a Medical Director, assuming responsibility for all medical functions in the Finnish affiliate of the company she represented. After this, Jaana has worked in different Medical Advisor/Director positions in different companies.

Jaana established Medaffcon in 2009 after working in the pharmaceutical industry for almost ten years. Jaana’s most essential input in Medaffcon’s team is her wide-ranging experience and knowledge in different fields of the pharmaceutical industry, as well as the ability to think innovatively. Jaana’s key areas of interests include creating and maintaining cooperation between different activities and actors in the pharmaceutical industry. Jaana is also a member of the Board of the Finnish Association of Pharmaceutical Physicians.


Päivikki Hemmilä
Scientific Advisor

Päivikki Hemmilä

Scientific Advisor
PhD

+35845 1200 632 LinkedIn

Päivikki joined Medaffcon’s Medical Affairs team in September 2017.  She has a PhD in cancer biology and worked for almost ten years as a researcher in the field. Since 2006, Päivikki has worked in different specialist positions with sales, quality, registration and research in Medical Device, pharmaceutical and CRO companies. Before joining Medaffcon Päivikki worked in Finnish Clinical Biobank Tampere, where she was responsible for the construction and development of the biobank’s quality system and operative processes.

Päivikki is intrigued by the constant development of the healthcare industry. In addition, she is interested in the possibilities and concrete benefits for developing a more effective and individualised treatment through cooperation between different actors, such as biobanks and research institutions.

At Medaffcon, Päivikki’s strengths include her solid scientific expertise as well as her wide-ranging experience in the project leader role in both academic and company-led research and product development projects. Päivikki works with a positive mind in a customer-oriented manner and makes for a reliable team player.


Outi Isomeri
Scientific Project Manager

Outi Isomeri

Scientific Project Manager
M. Sc. (Pharm.) & M. Sc. (Tech.)

+358 40 507 4092 LinkedIn

Outi Isomeri joined Medaffcon’s Medical Affairs team in December 2017. Outi holds plenty of experience from outpatient pharmaceutical service, particularly customer service and review of customer needs, after working as a pharmacist since 2009.

Outi holds a Master of Science degree in Technology, and she completed her Master’s thesis and advanced studies at the HEMA (Healthcare Engineering, Management and Architecture) institute at Aalto University, where she studied, inter alia, the management and arrangements in special healthcare. In addition to industrial engineering, her degree included health economics and analytics. Outi has worked as an analyst in different projects at NHG.

In the field, Outi is interested, in particular, in the future possibilities in individualised pharmaceutical treatment, the use of existing knowledge for the benefit of all and the possibilities to provide her own contribution for the benefit of a more functional pharmaceutical service in Finland. ”I strongly believe that there is a lot to improve in the operational models of our field, and I want to be part of analysing and planning those.” Furthermore, Outi holds an interest in market analyses and the assessment and monitoring of the overall costs of diseases.

Outi’s strengths include her diversity both as an employee and in terms of educational background. Outi is analytical, hard-working and customer-oriented professional in the pharmaceutical industry.


Krista Maurinen
Scientific Project Manager

Krista Maurinen

Scientific Project Manager
M.Sc. (Biomedicine)

+358 50 354 47 04 LinkedIn

Krista Maurinen joined Medaffcon in May 2017, assuming the position of a Scientific Project Manager. Krista has worked at GSK for the past three years, mainly as an Area and Key External Expert Manager with pain management as her main therapeutic area. In addition, Krista has experience in research and sales.

In the field, Krista is interested in constant development, changing lines of action and new innovations. Moreover, the development of transparent and ethical cooperation between physicians and the pharmaceutical industry is of interest to Krista.

Krista holds a degree education in Biomedicine and has gained extensive experience in working at the customer interface. Krista’s strengths include her solid presentation and human relations skills as well as her determination: “Nothing is impossible as long as we get the right people around the same table”.


Lasse Oinonen
Sr. Scientific Project Manager

Lasse Oinonen

Sr. Scientific Project Manager
M.Sc. (Pharmacy)

+358 40 1242 585 LinkedIn

Lasse started at Medaffcon in November 2014 as a Scientific Project Manager. Lasse has worked in the pharmaceutical industry since 2001 in different positions: ca. 6 years in sales (medicinal products for prostatic cancer and erectile disorder, antimicrobial, painkiller, anti-obesity agent), ca. 3 years in development/project work (obesity treatment), 5.5 years as a Scientific Expert (urology, nephrology, anaesthesiology) and as the substitute for a liable director. Lasse has a Master of Science (Pharmacy) degree, and since 2014, he is a Doctoral Student at the University of Tampere (in a hemodynamic research group).

In the field, Lasse is particularly interested in the constantly changing operational environment and different interest groups and the individualised acknowledgement of their needs, the significance of the cost benefit-effectiveness analysis of medicinal products in healthcare decision-making, as well as working with significant scientific data.

Lasse’s strengths include his wide-ranging experience in the pharmaceutical industry covering different therapeutic and operational areas and in Cross-functional team work in a matrix organisation.


Milla Summanen
Scientific Advisor

Milla Summanen

Scientific Advisor
PhD

+358 45 2380122 LinkedIn

Milla joined Medaffcon’s team in February 2019. Milla obtained her PhD in cell biology from Utrecht University in the Netherlands in 2012. The aim of her PhD research was to develop single-domain VHH antibodies that activate or inhibit protein kinase C epsilon in cells. She did part of the research at the Faculty of Pharmacy at the University of Helsinki. From 2014 until 2019 she worked as a postdoctoral researcher at the Laboratory of Neurobiology at the University of Helsinki, Faculty of Biological and Environmental Sciences.

Milla is especially interested in working with clinically relevant scientific data, in the possibilities of precision medicine, and in collaborating with the different stakeholders of the health care sector.

Milla’s strengths include a solid scientific background, excellent organizational skills, and a diverse and international educational background.


Elisa Tyynysniemi
Scientific Project Manager

Elisa Tyynysniemi

Scientific Project Manager
M.Sc. (Pharmaceutical Science)

+358 40 8394 369 LinkedIn

Elisa started at Medaffcon in January 2015 as a Scientific Project Manager. Previously, Elisa has worked in drug safety unit at Novo Nordisk A/S in Copenhagen as well as sales permit related tasks in the Finnish Medicines Agency Fimea. Working at the Department of Pathology of the University of Turku, Elisa has also gained several years of experience in medical research and in working in a hospital environment.

Elisa has completed a Master’s degree in a programme for international drug development at the University of Copenhagen. She completed her Master’s thesis at Novo Nordisk A/S headquarters in Copenhagen. Elisa also holds a Bachelor of Science degree at the University of Turku in Biomedicine. Therefore, she has completed studies in Medicine, Natural Sciences, Pharmacy and Economics.

Due to her strong theoretical background and work experience, Elisa has wide understanding of the objectives of drug development both from the industrial and authority perspectives. Elisa is particularly interested in developing new medicinal treatment and improving therapeutic value. She is also excited about working with multifunctional teams and constructing seamless cooperation between different interest groups.